does blue cross blue shield cover glp-1 medication IBX members face drug costs after insurance change GLP-1 Drugs: What Employers Need

At current prices, even with recent reductions under the Trump administration's Most-Favored-Nation pricing initiative (bringing Ozempic and Wegovy to $350/month through TrumpRx, with a $50 Medicare co-pay), that's a significant long-term commitment

Zepbound for weight management): Dual GIP/GLP-1 agonist showing superior weight loss (up to 22%) in SURMOUNT trials Oral option: These medications require proper patient selection and monitoring

The data analysis from the scoping review indicates that the impact of combined use on glucose control is more pronounced than the effect on weight reduction

Although these medications improve overall glycemic control, the combination of reduced food intake, delayed gastric emptying, and enhanced insulin secretion could theoretically affect glucose availability

The drugs offer great promise for the 40% of the US population struggling with obesity